Company Filing History:
Years Active: 1999
Title: Shigeru Iwaki: Innovator in Anti-Tumor Agents
Introduction
Shigeru Iwaki is a notable inventor based in Osaka-fu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor agents. His innovative work has led to the creation of a unique quinazoline compound that holds promise in cancer treatment.
Latest Patents
Shigeru Iwaki holds a patent for a quinazoline compound and an anti-tumor agent containing said compound. The patent describes a quinazoline compound of a specific formula, which is useful as an anti-tumor agent and as an active ingredient in pharmaceutical compositions. This invention showcases his commitment to advancing medical science and improving treatment options for patients.
Career Highlights
Iwaki is associated with Kanebo, Limited, where he has been able to apply his expertise in pharmaceutical research and development. His work at Kanebo has allowed him to focus on creating effective treatments that can make a difference in the lives of those battling cancer.
Collaborations
Shigeru Iwaki has collaborated with talented coworkers such as Yoshikazu Jinbo and Tomohiro Miyasaka. These partnerships have likely contributed to the innovative environment that fosters the development of groundbreaking pharmaceutical solutions.
Conclusion
Shigeru Iwaki's contributions to the field of anti-tumor agents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to inspire advancements in cancer treatment and showcases the importance of innovation in medicine.